Genes, Drugs and Stem Cells – Novel Therapies
Imperial College LondonGenes, Drugs and Stem Cells – Novel Therapies MSc is a postgraduate degree at Imperial College London, based in Islington, taught full-time over 1 year.
About this course
Gain proficiency in translational research and explore a range of next-generation therapies on this Master’s course.
You'll acquire transferable skills in translational research, exploring the steps required to progress novel therapies from bench-to-bedside and towards drug licensing.
You'll also build your knowledge of ethical and regulatory legislation, commercialisation strategies, and intellectual property and patent protection.
This course is unique in providing academic and laboratory research training in three key areas of advanced therapeutic development:
Gene and Nucleic Acid Based Therapies
Regenerative Medicine
New Horizons in Pharmacology
The blended study format offers flexibility in terms of learning, with the programme delivered through a mixture of face-to-face teaching, online learning, and self-study.
The MSc course allows you to pursue your speciality in greater depth, through a further advanced module and a six-month research project.
You’ll also gain a basic understanding of bioinformatics and their application in biology and take part in interdisciplinary team events to generate ideas for public engagement activities, or research projects.
Study Options
This course is available in 3 study options:
Duration: 1 Year
Qualification: MSc
Location: Islington
Duration: 1 Year
Qualification: MSc
Location: Hammersmith and Fulham
Duration: 1 Year
Qualification: MSc
Location: Kensington and Chelsea
Related Courses
Course Details
- Qualification
- MSc
- Study Mode
- Full-time
- Duration
- 1 Year
- Start Date
- 2025
- Academic Year
- 2025
- Campus / Location
- Islington
- Scheme
- Postgraduate
2025-entry data — 2026 offers may differ